Search results
Atossa Therapeutics is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology. Atossa’s current focus is on breast cancer.
- 1.3900Add to watchlist0.0000 (0.00%)At close:4:00 PM EDTThu. Sep 26, 20241.3900 0.00 (0.00%)After hrs:4:09 PM EDTThu. Sep 26, 2024Nasdaq Real Time Price (USD) · Market closed
- Open1.3900High1.4300Low1.3700
- Mkt. Cap174.8MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close1.390052 Wk. Low0.620052 Wk. High2.3100
Related stocks
Atossa (Old Persian: Utauθa, or Old Iranian: Hutauθa; 550–475 BC) was an Achaemenid empress. She was the daughter of Cyrus the Great, the sister of Cambyses II, the wife of Darius the Great, the mother of Xerxes the Great and the grandmother of Artaxerxes I.
Find the latest Atossa Therapeutics, Inc. (ATOS) stock quote, history, news and other vital information to help you with your stock trading and investing.
Oct 15, 2023 · Queen Atossa was a force to reckon with in the Achaemenid Empire. As strategic leader, and mother to a future emperor, her impact echoes through time. The famed Achaemenid Empire was an ancient Iranian empire that was founded by the renowned Cyrus the Great in 550 BC.
Atossa has developed a proprietary oral formulation of (Z)-endoxifen that does not require liver metabolism to achieve therapeutic concentrations and is encapsulated to bypass the stomach as acidic conditions may render (Z)-endoxifen inactive.
Steven Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS).
Nov 20, 2023 · Atossa is developing a proprietary oral formulation of (Z)-endoxifen that does not require liver metabolism to achieve therapeutic concentrations and is encapsulated to bypass the stomach as ...
